Harvard Bioscience, Inc. (HBIO) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Harvard Bioscience, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.398 -- 00:00:06.405 Good day and welcome to the fourth quarter and full year 2025 Harvard Bioscience 00:00:06.405 -- 00:00:10.751 Earnings Conference Call. All participants will be in a listen-only mode. 00:00:10.751 -- 00:00:14.577 After today's presentation, there will be a question and answer session. 00:00:14.577 -- 00:00:18.523 Instructions will be given at that time. Please note this event is being recorded. 00:00:18.523 -- 00:00:23.209 I would like to turn the conference over to Taylor Krafcik, Senior Vice President at 00:00:23.209 -- 00:00:26.872 Ellipsis TA. Please go ahead. 00:00:27.355 -- 00:00:29.815 Thank you, Operator, and good morning, everyone. 00:00:29.815 -- 00:00:33.840 Thank you for joining the Harvard Bioscience fourth quarter and full year 2025 earnings 00:00:33.840 -- 00:00:38.205 conference call. Leading the call today will be John Duke, President and Chief Executive 00:00:38.205 -- 00:00:41.048 Officer, and Mark Frost, Chief Financial Officer. 00:00:41.048 -- 00:00:44.653 In conjunction with today's call, we've provided a presentation that will be referenced 00:00:44.653 -- 00:00:48.677 during our remarks that is posted to the investor relations section of our website at 00:00:48.677 -- 00:00:50.677 investor.harvardbioscience.com. 00:00:52.121 -- 00:00:56.046 Please note that statements made in today's discussion that are not historical facts, 00:00:56.046 -- 00:01:01.352 including statements on management, Expectations of future events or future financial 00:01:01.352 -- 00:01:06.079 performance are forward-looking statements and are made pursuant to safe harbor provisions 00:01:06.079 -- 00:01:10.104 of the Private Securities Litigation Reform Act of 1995. 00:01:10.104 -- 00:01:14.110 These forward-looking statements reflect...